Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Javlor |
|---|---|
| Manufacturer | Pierre Fabre Pharma GmbH |
| Prescription required | Yes |
Javlor 25mg/ml Infusionslsgm,1 x 2ml(vinflunine)
vinflunine
Description
Javlor 25mg/ml Infusionslsgm,1 x 2ml(vinflunine) is a medicine catalog record in the MediPriceHub database. Active ingredient: vinflunine. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Pierre Fabre Pharma GmbH. Therapeutic category: Medicine Library > Oncology Medicines > Bladder Cancer Medicines. Pack information: 25 / 1 X2. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
Vinflunine is a vinca alkaloid chemotherapy medicine used for advanced or metastatic transitional cell carcinoma of the urothelial tract after prior platinum-containing therapy where approved.How to Use
Pierre Fabre Pharma GmbH Vinfluninbis((R,R)-tartrat) 68,5mg = Vinflunin 50mgSpecification
Active ingredient: vinflunine. Pack size: 25 / 1 X2. Pack unit: bottle. Manufacturer: Pierre Fabre Pharma GmbH. Origin country: Germany. Source category: Medicine Library > Oncology Medicines > Bladder Cancer Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Injectable and infusion products may also cause administration-site pain, swelling, infection, infusion reactions, or hypersensitivity. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Ces informations sont fournies à titre indicatif. Demandez conseil à un professionnel de santé avant d'utiliser un médicament.